Skip to content

IMDX IMDX Financing Cash Flow

Financing Cash Flow at other companies

CareDx logo
CareDxCDNA
-$2.91M-353%
Guardant Health logo
Guardant HealthGH
-$21.58M+67.7%
Natera, Inc. logo
Natera, Inc.NTRA
$3.76M+591%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
-$44.83M-301%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
-$44M+55.0%
Agilent Technologies logo
Agilent TechnologiesA
-$144M-24.1%

Other financials

Income statement

See full
Revenue$32.0K-98.5%
Gross profit$15.0K-98.9%
Operating income-$4.4M+35.1%
Net income-$4.3M+35.7%
EPS (diluted)-$0.12+53.8%

Balance sheet

See full
Cash & equivalents$28.2M-9.1%
Total debt$2.9M-13.5%
Total equity-$10.7M-205%
Total assets$40.4M-33.0%

Cash flow

See full
Operating cash flow-$7.6M-30.8%
CapEx$613.0K+99.7%
Free cash flow-$8.3M-34.3%

Valuation

See full
Market cap$185.35M+92.3%
Enterprise value$160.03M+113%
P/S95.1×+72.5×

Profitability

See full
Gross margin51.3%-3.0pp
Operating margin-2,500.7%+4,459pp
Net margin-2,454.6%+4,017pp
FCF margin-1,409.7%-6,023pp

Returns & leverage

See full
Return on equity-532.9%-717pp
Debt / equity2.9×+2.8×
Current ratio2.5×-1.2×

Where this comes from

Reported directly by IMDX in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: IMDX’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about IMDX's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IMDX's financing cash flow?
IMDX (IMDX) reported financing cash flow of $24.7M in Q1 2026.
How has IMDX's financing cash flow changed year-over-year?
IMDX's financing cash flow decreased by 13.5% year-over-year, from $28.56M to $24.7M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.